Statins reduce peri-procedural complications in carotid stenting

Area of Science:

• Cardiology
• Neurology
• Vascular Surgery

Background:

• Statins are proven to reduce cardiovascular and cerebrovascular events.
• Limited data exist on pre-interventional statin use in carotid artery stenting compared to endarterectomy.
• Investigating statin's role in peri-interventional risk reduction for carotid stenting is crucial.

Purpose of the Study:

• To determine if pre-interventional statin therapy is associated with reduced peri-interventional risk.
• To analyze the impact of statins on stroke, myocardial infarction, and mortality in carotid stenosis patients undergoing stenting.

Main Methods:

• Retrospective analysis of 344 patients with internal carotid artery stenosis treated with stent-angioplasty (2002-2012).
• Data collected prospectively, including risk factors, medications, and indications for therapy.
• Univariate and multivariate analyses performed to assess independent effects of statin medication.

Main Results:

• 60.2% of patients received pre-interventional statin medication.
• Multivariate analysis showed statins significantly reduced the risk of peri-interventional ischemic stroke, myocardial infarction, or death (OR 0.31, p = .006).
• Statins also demonstrated a protective effect on secondary endpoints, including ischemic stroke, intracranial bleeding, or death (OR 0.39, p = .014).

Conclusions:

• Pre-interventional statin medication offers a protective effect against peri-interventional stroke, myocardial infarction, or death in carotid stenting.
• Statins should be considered a standard pre-interventional therapy for patients undergoing carotid stenting.
• This supports the broader use of statins in cardiovascular prevention strategies.